ANTICORPS SPECIFIQUES A CD47 ET PD-L1

• 收藏
• 分享

专利权人:

JOINT STOCK COMPANY "BIOCAD"

发明人:

SOLOVYEV, KIRILL VLADIMIROVICH,ULITIN, ANDREI BORISOVICH,NEMANKIN, TIMOFEY ALEKSANDROVICH,SOLOVYEV, VALERY VLADIMIROVICH,MOROZOV, DMITRY VALENTINOVICH

申请号：

CA3078413

公开号：

CA3078413A1

申请日:

2018.10.03

申请国别(地区):

CA

年份:

2019

代理人:

摘要：

The present invention relates to the field of bioengineering, specifically to antibodies or their antigen-binding fragments, and to the use thereof. More particularly, the present invention relates to antibodies that bind specifically to CD47 and PD-L1. The invention also relates to a nucleic acid that codes for the given antibody or for the antigen-binding fragment thereof, to an expression vector, to a method of producing the antibody, and to a use of the aforementioned antibodies and compositions in cancer treatment.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/